疾病严重程度与IgG4相关病自身抗体多样性增加相关
该研究在100例IgG4相关病患者中检测针对prohibitin、annexin A11和laminin 511-E8的自身抗体,并结合既往galectin-3抗体数据。37%患者对至少1种自身抗原有IgG4抗体,14%对至少2种有反应,后者IgG亚类升高、补体消耗及内脏受累更常见。
要点
- 37%的IgG4-RD患者对至少1种自身抗原有IgG4抗体反应。
- 14%患者对至少2种自身抗原有反应,与更严重疾病表型相关。
- 多重自身抗体阳性者IgG1、IgG2、IgG4及CRP更高,低补体及内脏受累更常见。
核心结论
- 部分IgG4-RD患者对至少2种自身抗原产生IgG4抗体,这种更广泛的免疫耐受破坏与更严重疾病相关。
研究设计与样本
- 在100例临床多样的IgG4-RD患者队列中,用酶联免疫吸附试验检测针对prohibitin、annexin A11和laminin 511-E8的自身抗体反应。
- 其中86例既往在本中心检测过抗galectin-3抗体反应,25例(29%)有IgG4抗galectin-3抗体。
主要发现
- 针对prohibitin(10%)、annexin A11(12%)和laminin 511-E8(7%)的IgG4自身抗体反应频率与对照无显著差异。
- 86例中32例(37%)对4种自身抗原中至少1种有IgG4抗体,12例(14%)对至少2种受检抗原有反应。
- 对至少2种自身抗原有反应的患者IgG1、IgG2、IgG4总量及C反应蛋白更高,更常见低补体血症,更可能有内脏器官受累。
关键数值与推荐
- 针对prohibitin的IgG4抗体反应频率为10%,针对annexin A11为12%,针对laminin 511-E8为7%,与对照无显著差异。
- 86例中25例(29%)有IgG4抗galectin-3抗体,32例(37%)对至少1种自身抗原有IgG4抗体,12例(14%)对至少2种有反应。
临床怎么用
- 对IgG4-RD患者可关注多重自身抗体阳性亚群,该亚群更常见IgG亚类升高、补体消耗和内脏受累,提示疾病更严重。
局限性
- 抗galectin-3抗体数据来自既往在本中心检测的86例子集,非全部100例同步检测。
- 针对prohibitin、annexin A11和laminin 511-E8的抗体反应频率与对照无显著差异,外部验证有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Four autoantigens have been described recently in IgG4-related disease (IgG4-RD): prohibitin, annexin A11, laminin 511-E8, and galectin-3. However, no external validation has been performed, and the possibility that some individuals break tolerance to more than 1 autoantigen has not been explored. We undertook this study to evaluate the relative frequencies of antibody responses against these autoantigens in order to explore the role of adaptive immune response in IgG4-RD. METHODS: Autoantibody responses against prohibitin, annexin A11, and laminin 511-E8 were measured among a clinically diverse cohort of IgG4-RD patients (n = 100) using enzyme-linked immunosorbent assays. Autoantibody responses were correlated with disease severity and organ distribution. RESULTS: The frequencies of IgG4 autoantibody responses against prohibitin (10%), annexin A11 (12%), and laminin 511-E8 (7%) were not significantly different from those of controls. A portion of the cohort (n = 86) had been analyzed previously at our center for anti-galectin-3 antibody responses, with 25 patients (29%) having IgG4 anti-galectin-3 antibodies. Of these 86 patients, 32 (37%) had IgG4 antibodies to ≥1 of the 4 autoantigens and 12 (14%) showed reactivity with ≥2 of the tested antigens. The subset of patients with ≥2 autoantibodies had higher total levels of IgG1, IgG2, IgG4, and C-reactive protein, were more commonly hypocomplementemic, and were more likely to have visceral organ involvement. CONCLUSION: Antibodies against prohibitin, annexin A11, and laminin 511-E8 were found in only a small portion of patients with IgG4-RD. A subset of IgG4-RD patients, however, had IgG4 antibodies against ≥2 autoantigens. These patients presented with robust IgG subclass elevations, complement consumption, and visceral organ involvement. This broader break in immunologic tolerance in IgG4-RD was associated with more severe disease.
引用
- Liu H, Perugino CA, Ghebremichael M, et al. Disease Severity Linked to Increase in Autoantibody Diversity in IgG4-Related Disease. Arthritis Rheumatol. 2020. PMID: 31612628. doi:10.1002/art.41140
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。